Abstract
In the early 1900s many diabetic patients died of overwhelming infection. The introduction of insulin dramatically altered this situation and today the major cause of death in diabetic patients are the noncommunicable diseases such as cardiovascular disease. However, infections in diabetic patients still represent an important issue. This chapter discusses the various aspects that need to be considered both by doctors involved in caring for these patients and by the authorities responsible for calculating the costs of diabetes care.
References
- 1 Smitherman KO, Peacock JE. Infectious emergencies in patients with diabetes mellitus. Med Clin North Am 1995; 79: 53–77.
- 2 Wheat LJ. Infection and diabetes mellitus. Diabetes Care 1980; 3: 187–97.
- 3 Vejilsgaard R. Studies on urinary infection in diabetes. Bacteria in patients with diabetes mellitus and in control subjects. Acta Med Scand 1966; 179: 173–8.
- 4 Bebrod L. Infections in the diabetic patients. Clin Diabetes 1985; 3: 98–105.
- 5
Berdade JD,
Segreti J.
The infectious emergencies of diabetes.Endocrinologist
1991;
1:
155–61.
10.1097/00019616-199106000-00004 Google Scholar
- 6 Leslie CA, Sapico FL, Bessman AN. Infections in the diabetic host. Compr Ther 1989; 15: 23–32.
- 7 Sapico FL, Bessman AN. Infections in the diabetic patient. Infect Dis Clin Pract 1992; 1: 339–43.
- 8 Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003; 49: 53–70.
- 9 Harding GK, Zhanel GG, Nicolle LE, Cheang M.Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347: 1576–83.
- 10 Mendoza T, Garzia de los, Rios M, Lafourcade M, Soto C, Durruty P, Alvo M. Asymptomatic bacteriuria in type 2 diabetics women. Rev Med Chil 2002; 130: 1001–7.
- 11 Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26: 510–3.
- 12 Greenwood AM. A study of the skin in five hundred cases of diabetes. JAMA 1927; 89: 774–80.
- 13 Pell S, D'Alonzo CA. Sickness absenteeism in employed diabetics. Am J Public Health 1967; 57: 253–8.
- 14
Robbins SL,
Tucker AW Jr.
The causes of death in diabetics.
A report of 307 autopsied cases.
New Engl J Med
1944;
231:
865–9.
10.1056/NEJM194412282312601 Google Scholar
- 15 World Health Organization. Immunodeficiency: Report of a Scientific Group. Technical Report Series 630. Geneva: World Health Organization, 1978.
- 16 Janeway CA. How the immune system works to protect the host from infection: a personal view. PNAS 2001; 98: 7461–8.
- 17 Shi FD, Wong HB, Li H, Hong S, Taniguchi M, Link H, Van Kaer L, Ljunggren HG. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 2000; 1: 245–51.
- 18 Mackay I,Rosen FS.Innate immunity. New Engl J Med 2000; 343 (5): 338–43.
- 19 Wilson SB, Kent SC, Patton KT, et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391: 177–81.
- 20 Sharif S,Arreaza GA, Zucker P, et al. Activation of natural killer cells by a-galactosylcermide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 2001; 9: 1057–61.
- 21 Tafuri A,Bowers WE, Handler ES, et al. High stimulatory activity of dendritic cells from diabetes-prone BB/Worcester rats exposed to macrophage-derived factors. J Clin Invest 1993; 91: 2040–8.
- 22 Jansen A, Van Hagen M, Drehxhage HA, et al. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995; 345: 491–2.
- 23 Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabète Métab 1992; 18: 187–201.
- 24 Wilson RM, Reeves WG. Neutrophil function in diabetes. In M Nattrass (ed). Recent Advances in Type 2 Diabetes. London: Churchill Livingstone 1986; pp 127–38.
- 25 Monboisse JC, Rittie L,Lamfarraj H, Garnotel R, Gillery P. in vitro glycoxidation alters the interactions between collagen and human polymorphonuclear leucocytes. Biochem J 2000; 3: 777–83.
- 26 Collison KS, Parhar RS, Saleh SS,Meyer BF,Kwaasi AA, Hammam MM, Schmidt AM, Stern DM,Al-Mohanna FA. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol March 2002; 71: 433–44.
- 27 Walenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation July 11, 2000; 102: 185–90.
- 28 Simmons D, Leong LNG, Bomford J. Abnormal myoinositol influx in human leukocytes in diabetes but not specifically in diabetic neuropathy. Diabetes 1992; 41: 760–65.
- 29 Wykretowicz A, Wierusz-Wysocka B. Infection and diabetes: role of polymorphonuclear neutrophils. In P Pozzilli, A Signore (eds). Diabetes Prevention and Therapy, Vol. 6. Chichester, UK: Wiley, 1992; p 27.
- 30 Sawant JM. Biochemical changes in polymorphonuclear leukocytes in diabetic patients. J Postgrad Med 1993; 39: 183–6.
- 31 Chiari SN, Nath N. Sialic acid content and sialidase activity of polymorphonuclear leukocytes in diabetes mellitus. Am J Sci 1984; 288: 1–5.
- 32 Gin H, Brottier E, Aubertin J. Influence of glycaemic normalization by an artifical pancreas on phagocytic and bacterial functions of granulocytes in insulin-dependent diabetic patients. J Clin Pathol 1984; 37: 1029–31.
- 33 Wilson RM, Tomlinson RA, Reeves WG. Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabet Med 1987; 4: 37–40.
- 34 Horita M,Sunzuki H, Onodera T, Ginsberg-Fellner F, Fauci AS,Notkins AL. Abnormalities of immunoregulatory T-cell subsets in patients with insulin dependent diabetes mellitus. J Immunol 1982; 129: 1426–9.
- 35 Rodier M, Andary M,Richard JL, Mirouze J, Clot J. Peripheral blood T cell subsets studied by monoclonal antibodies in type 1 (insulin-dependent) diabetes: effect of blood glucose control. Diabetologia 1984; 27: 136–8.
- 36 Pozzilli P, Negri M, Visalli N, Pagani S,Beales P,Andreani D. Impaired CD4/CD8 lymphocyte ratio in patients with long-standing diabetes mellitus. IRCS Med Sci 1986; 14: 648–9.
- 37 Drell DW,Notkins AL. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 132–43.
- 38 Visalli N, Signore A, Pozzilli P. Immunodeficiency in long-standing diabetes: evidence and approaches to prevention. In D Andreani, H Kolb, P Pozzilli (eds). Immunotherapy of Type 1 Diabetes. Chichester, UK: Wiley, 1989; pp 185–92.
- 39 Pozzilli P, Pagani S,Arduini P, Visalli N, Cioccia GP, Negri D. In vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser. Diabetes Res 1987; 6: 5–8.
- 40 Pozzilli P, Gale EAM,Visalli N, Baroni MG, Crovari P, Frighi V, et al. The immune response to influenza vaccination in diabetic patients. Diabetologia 1986; 29: 850–5.
- 41 Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C, et al. Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30: 817–9.
- 42 Smith WI,Rabin BS, Huellmantel A, van Thiel DH, Drash A. Immunopathology of juvenile onset diabetes mellitus, I: IgA deficiency and juvenile diabetes. Diabetes 1978; 27: 1092–7.
- 43 Hoddinott S, Dornan J, Bear JC, Farid NR.Immunoglobulin levels, immunodeficiency and HLA in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982; 23: 326–9.
- 44 Lederman MM, Rodman HM, Schaeter BZ, Jones PK,Schiffman G. Antibody response to pneumococcal polysaccharides in insulin-dependent diabetes mellitus. Diabetes Care 1982; 5: 36–9.
- 45 Palmer JP, Cooney MK, Ward RH, Hansen JA, Brodsky JB, Ray CG, et al. Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection. Diabetologia 1982; 22: 426–9.
- 46
Vergani D,
Johnston C,
B-Abdullah N,
Barnett AH.
Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes?
Br Med J
1983;
286:
943–8.
10.1136/bmj.286.6369.926 Google Scholar
- 47 Charlesworth JA, Timmermans V, Golding J, Campbell LV, Peake PW,Pussell BA, et al. The complement system in type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30: 372–9.
- 48 Boulton AJM. The importance of abnormal foot pressures and gait in the causation of foot ulcers. In H Connor, AJM Boulton, JD Ward (eds). The Foot in Diabetes. Chichester, UK: Wiley, 1987; pp 11–21.
- 49 Wheat LJ,Allen SD,Henry M, Kernek CB, Siders JA, Kuebler T, et al. Diabetic foot infections. Arch Intern Med 1986; 146: 1935–40.
- 50 Cluff LE,Reynolds RC, Page DL. Staphylococcal bacteremia: demographic, clinical and microbiological features of 185 cases. Trans Am Clin Climatol Assoc 1968; 79: 905–15.
- 51 Tapper-Jones LM, Aldred MJ, Walker DM, Hayes TM.Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 1981; 34: 706–11.
- 52 Pietri A, Raskin P.Cutaneous complications of chronic continuous subcutaneous insulin infusion therapy. Diabetes Care 1981; 4: 624–6.
- 53 Ryan EA, Miller J, Skyler JS. Finger sepsis. Possible complication of self-monitoring of blood glucose concentrations. Br Med J 1983; 286: 1614–5.
- 54 Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of the specialised foot clinic. Q J Med 1986; 60: 763–71.
- 55 Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors and the role of antimicrobial surgical therapy. Am J Med 1987; 83: 653–60.
- 56 Giuliano A, Lewis F Jr, Hadley K, Blaisdell FW. Bacteriology of necrotizing fascitis. Am J Surg 1977; 134: 52–7.
- 57 Sen P, Louria DB. Infectious complications in the elderly diabetic patient. Geriatrics 1983; 38: 63–6.
- 58 Smith JA, O'Connor JJ, Welles AT. Nasal carriage of Staphylococcus aureus in diabetes mellitus. Lancet 1966; 2: 776–81.
- 59 Somerville DA, Lancaster-Smith M. The aerobic cutaneous microflora of diabetic subjects. Br J Dermatol 1973; 89: 395–401.
- 60 Minchew BH. Studies of the epidemiology of staphylococcal infections, VIII: infection in hospital personnel. Bull Johns Hopkins Hosp 1964; 114: 313–5.
- 61 Farrer SM, MacLeod CM. Staphylococcal infections in a general hospital. Am J Hyg 1960; 72: 38–58.
- 62 Mugusi F, Swai AB, Alberti KGMM, McLarty DG. Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 1990; 71: 270–6.
- 63 Sarkany I, Taplin D, Blank H. Erythrasma—common bacterial infection of the skin. JAMA 1961; 177: 130–2.
- 64 Feingold DS, Wagner RF Jr. Antibacterial therapy. J Am Acad Dermatol 1986; 14: 535–48.
- 65 Chandler JR. Malignant external otitis: further considerations. Ann Otol Rhinol Laryngol 1977; 86: 417–28.
- 66 Grossi SG. Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol 2001; 6: 138–45.
- 67 Page RC. Vaccination and periodontitis: myth or reality. J Int Acad Periodontol April 2000; 2 (2): 31–43.
- 68 Bessman AN, Wagner W. Nonclostridial gas gangrene. Report of 48 cases and review of the literature. JAMA 1975; 233: 958–63.
- 69 Alteras I, Saryt E. Prevalence of pathogenic fungi in the toe-webs and toe-nails of diabetic patients. Mycopathologia 1979; 67: 157–60.
- 70 Sonck CE, Somersalo O. The yeast flora of the anogenital region in diabetic girls. Arch Dermatol 1963; 88: 846–50.
- 71
Stone OJ,
Mullins JF.
Incidence of chronic paronychia.
JAMA
1963;
186:
177–8.
10.1001/jama.1963.63710010028022b Google Scholar
- 72 Batra VK, Gaiha M, Gupta PS. Mucormycosis in a diabetic. Postgrad Med J 1982; 58: 781–2.
- 73 Hamill R, Oney LA, Crane LR. Successful therapy for rhinocerebral mucormycosis with associated bilateral brain abscesses. Arch Intern Med 1983; 143: 581–3.
- 74 Dogras S, Kumar B, Bhansali A, Chakrebarty A. Epidemiology of onycomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002; 41: 647–51.
- 75 Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. New Engl J Med 1994; 331: 854–60.
- 76 Zimmerman RK, Middleton DB, Smith NJ. Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle. J Fam Pract January 2003; 52 (1, suppl): S22–35.
- 77 Chen D, Misra A, Garg A. Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab 2002; 87 (11): 4845–56.
- 78 The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977–86.
- 79 Storm AJ, Bouter KP, Diepersloot RJ, Erkelens DW. Large variation in the treatment of foot infections in diabetic patients in The Netherlands. Ned Tijdschr Geneeskd 1994; 138: 569–73.
- 80 Lipsky BA, Pecoraro RE, Larson SA, Hanley ME, Ahroni JH. Out-patient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990; 150: 790–7.
- 81 Kaufmann J, Breeding L, Rosenberg N. Anatomic location of acute diabetic foot infection. Its influence on the outcome of treatment. Am Surg 1987; 53: 109–12.
- 82 Abbas ZG, Gill GV, Archibald LK. The epidemiology of diabetic limb sepsis: an African perspective. Diabet Med 2002; 19: 895–9.
- 83 Meiland R, Geerlings SE, Hoepelman AI. Management of bacterial urinary tract infections in adult patients with diabetes mellitus. Drugs 2002; 62 (13): 1859–68.
- 84 Stapleton A. Urinary tract infections in patients with diabetes. Am J Med July 8, 2002; 113 (suppl 1A): 80S–84S.
- 85 Oriani G, Michael M, Meazza D, Sacchi C, Ronzio A, Montino O, et al. Diabetic foot and hyperbaric oxygen therapy: a ten-year experience. J Hyperbaric Med 1992; 7: 213–21.
- 86 Bakker DJ. Hyperbaric oxygen therapy and the diabetic foot. Diabetes Metab Res Rev 2000; 16 (suppl 1): S55–8.
- 87 Leslie CA, Sapico FL, Ginunas VJ, Adkins RH. Randomized controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers. Diabetes Care 1988; 11: 111–5.
